miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9

被引:21
|
作者
Qin, Kun [1 ]
Tian, Ge [2 ]
Chen, Guangzhong [1 ]
Zhou, Dong [1 ]
Tang, Kai [1 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源
JOURNAL OF GENE MEDICINE | 2020年 / 22卷 / 03期
关键词
glioma; HOXA9; miR-647; tumor suppressor; EXPRESSION; CANCER; MIGRATION; MICRORNAS;
D O I
10.1002/jgm.3153
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background MicroRNA-647 (miR-647) has been reported to regulate tumor development, although its role in glioma remains unclear. Methods miR-647 expression in glioma cells and normal cells was measured using a quantitative real-time polymerase chain reaction. The effects of miR-647 expression on glioma cell proliferation, cell apoptosis, colony formation and cell invasion were measured using a cell counting kit-8 assay, flow cytometry, a colony formation assay and a transwell invasion assay. Luciferase activity reporter and western blot assays were conducted to explore whether homeobox A9 (HOXA9) was a direct target of miR-647. Results We found that miR-647 expression was downregulated in glioma cell lines compared to the normal cell line. Overexpression of miR-647 inhibits glioma cell proliferation, colony formation and cell invasion, although it promotes apoptosis in vitro. HOXA9 was validated a direct target of miR-647 and the overexpression of HOXA9 reversed the effects of miR-647 on glioma cell behavior. Conclusions The identification of the miR-647/HOXA9 axis will advance our understanding underlying glioma progression and provide novel therapeutic targets for glioma treatment.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis
    Xiao, Gaopeng
    Yu, Liuqiong
    Tan, Wenmin
    Yang, Hao
    Li, Wensen
    Xia, Rongzhou
    Li, Yujin
    METABOLIC BRAIN DISEASE, 2023, 38 (01) : 233 - 244
  • [2] Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis
    Gaopeng Xiao
    Liuqiong Yu
    Wenmin Tan
    Hao Yang
    Wensen Li
    Rongzhou Xia
    Yujin Li
    Metabolic Brain Disease, 2023, 38 : 233 - 244
  • [3] RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9
    Yu, Junyan
    Tian, Xiangyang
    Chang, Jianlan
    Liu, Ping
    Zhang, Rong
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 782 - 791
  • [4] miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway
    Yang, Chao
    Chen, Yang
    Xiong, Wenhua
    Xu, Ke
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [5] Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion
    Yu, Seong-Lan
    Koo, Han
    Lee, Hoi Young
    Yeom, Young Il
    Lee, Dong Chul
    Kang, Jaeku
    CELLULAR ONCOLOGY, 2019, 42 (03) : 275 - 285
  • [6] Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion
    Seong-Lan Yu
    Han Koo
    Hoi Young Lee
    Young Il Yeom
    Dong Chul Lee
    Jaeku Kang
    Cellular Oncology, 2019, 42 : 275 - 285
  • [7] MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma
    Zheng, D-H
    Wang, X.
    Lu, L-N
    Chen, D-L
    Chen, J-M
    Lin, F-M
    Xu, X-B
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7798 - 7806
  • [8] 前列腺癌患者癌组织中miR-647和HOXA9表达水平及其与预后的关系分析
    易秋阳
    梁陈
    姚超
    中国男科学杂志, 2023, 37 (01) : 41 - 47
  • [9] HOXA9 gene inhibits proliferation and differentiation and promotes apoptosis of bovine preadipocytes
    He, Lixia
    Feng, Xue
    Hu, Chunli
    Liu, Shuang
    Sheng, Hui
    Cai, Bei
    Ma, Yun
    BMC GENOMICS, 2024, 25 (01)
  • [10] LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647
    Qian, C.
    Liao, C. -H.
    Tan, B. -F.
    Chen, Y. -F.
    Dang, B. -W.
    Chen, J. -L.
    Liu, C. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (17) : 8628 - 8628